News & Events


Celgene , bis repetita placent ?

Juno stock jumps as reports suggest Celgene wants a buyout


Celgene Scoops Up San Diego Biotech in $7B Deal

Celgene Scoops Up San Diego Biotech in $7B Deal


Pfizer pays Arvinas $830m to discover drugs that target mis-folded proteins

Pfizer pays Arvinas $830m to discover drugs that target mis-folded proteins


Novartis to test Intec’s Accordion controlled-release delivery tech

Novartis to test Intec’s Accordion controlled-release delivery tech


Teva , a major cost cutting plan announced during JPM Conference

Teva , a major cost cutting plan announced during JPM Conference


Charles River acquires UK-based KWS BioTest for $20m

Charles River Laboratories has acquired UK based CRO KES BioTest


New offering applies Chiltern-developed engagement models

Drug Development Business of Labcorp has launched a new dedicated offering for Biotech, medical device and diagnostic companies


Immune Issue around CRISPR-Cas9 : Is that a show stopper?

A number of people may have a natural immunity to the Cas9 proteins


Overlooked immune cells hold breakthrough for treating aggressive cancers

T cells with high levels of CD26 are excellent cancer fighters which will help advance the use of T cell-based immunotherapies for cancer and other autoimmune diseases.

Get in touch

Subscribe to Eclosion Newsletter

 

CONTACT US
© 2016 Fondation Eclosion
All rights reserved
Webdesign: Comstone / Pierre Chassany
WordPress Development: Olivier Gisiger